Related Experiment Videos

Delayed response to granulocyte colony-stimulating factor (G-CSF) in a case of severe neutropenia associated with

I Genvresse, E Späth-Schwalbe, A Lukowsky

European Journal of Haematology

|March 21, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.

British journal of cancer·2018

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Metastatic breast cancer: are we treating the same patients as in the past?

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer.

Breast cancer research and treatment·2012

See all related articles